• About
  • Advertise
  • Privacy & Policy
  • Contact
Wednesday, March 18, 2026
  • Login
  • Register
thehopper.news
  • Home
    • Home
    • About
    • Editorial Standards
    • Methodology & Sources
  • Briefings
    • Weekly
  • Analysis
  • Regions
    • Africa
    • Americas
    • Asia-Pacific
    • Europe & NATO
    • Middle East & North Africa
    • Russia & Eurasia
  • Themes
    • Energy & Reources
    • Intelligence & Security
    • Economics & Sanctions
    • Foreign Relations & Diplomacy
    • Cyber & Disinformation
  • Video
  • Aggregated
    • RT
    • Opinion
    • News
    • Geopolitics
    • Politics
    • Business
    • World
No Result
View All Result
thehopper.news
No Result
View All Result
Home Aggregated News

Cause of Friends star’s death revealed

by Admin
December 16, 2023
in News, Politics, World
0
Cause of Friends star’s death revealed
27
SHARES
109
VIEWS
Share on FacebookShare on Twitter

Published: December 16, 2023 9:49 am
Author: RT

Matthew Perry’s passing in late October was brought on by the “acute effects of ketamine,” the coroner’s office concluded

The death of Canadian-American actor Matthew Perry in late October was caused by the powerful anesthetic ketamine, which is also used recreationally and as alternative therapy for a range of psychological conditions, the LA County Department of Medical Examiner has revealed.
Perry, who rose to stardom with his role as Chandler Bing in the sitcom ‘Friends’, had for years struggled with alcohol and substance abuse, which he opened up about in his 2022 memoir, as well as numerous media interviews.

In a press release published on Friday, the coroner’s office said Perry’s passing was brought on by the “acute effects of ketamine,” namely, “cardiovascular overstimulation and respiratory depression.”

“Drowning, coronary artery disease, and the effects of buprenorphine (used to treat opioid use disorder)” were named as contributing factors.

Read more

FILE PHOTO
‘Friends’ star dies in hot tub – media

The actor was found unresponsive in a hot tub in his Los Angeles home on October 28 by his live-in assistant, who called 911. Paramedics pronounced the 54-year-old dead at the scene. The incident was initially treated as a “water rescue,” as reported by NBC at the time.

The autopsy confirmed that Perry had been receiving ketamine infusion therapy, adding, however, that the last session had taken place one and a half weeks before his death. The coroner thus ruled out the idea that it could have led to his death in and of itself.

Back in October, the Food and Drug Administration issued an alert, warning against the dangers of ketamine, which has recently gained popularity for treating psychological and psychiatric disorders. Perry’s assistant said in a witness statement that the Friends star had indeed been seeing a psychiatrist, and had also been on the opioid buprenorphine.

The actor joined the iconic sitcom’s cast in 1994 when he was 24. The final season was released in 2004. The series has come to attract a cult following over the years. Perry also starred in movies such as ‘Fools Rush In’ with his father and Salma Hayek, ‘The Whole Nine Yards’ with Bruce Willis, ‘Three to Tango’, ‘The Kid’, ’17 Again’, ‘Getting In’, and many others.

Full Article

Tags: Russia Today
Share11Tweet7
Previous Post

London mayor won’t send Ukraine cars destined for scrap – Telegraph

Next Post

‘So many people have died’: This Indian director conquered Russia with stories from his homeland

Admin

Admin

Next Post
‘So many people have died’: This Indian director conquered Russia with stories from his homeland

‘So many people have died’: This Indian director conquered Russia with stories from his homeland

  • Trending
  • Comments
  • Latest
The TRUTH behind the Secret Space Program and Alien Recovery is starting to come out

The TRUTH behind the Secret Space Program and Alien Recovery is starting to come out

January 19, 2026
European military stocks fall as Ukraine peace hopes rise

European military stocks fall as Ukraine peace hopes rise

August 20, 2025

New Mossad recruitment ads exploit Iran’s unrest with help from US comedian

January 19, 2026
Iranian drone intercepted over Dubai UAE March 2026 Operation Epic Fury

The Hopper Daily Brief — March 3, 2026 — Iran Escalates Against Gulf Targets

2
Smoke rising over Manama Bahrain near U.S. Fifth Fleet headquarters following Iranian missile strike February 2026

Bahrain’s Shia Majority Threatens the U.S. Navy’s Most Critical Gulf Command Node

2
Oil tankers idle in Persian Gulf and Trump demands Iran unconditional surrender — week of March 1–7, 2026 Hopper Weekly Brief

The Hopper Weekly Brief — Week 10, March 1-7, 2026

2

Shooting at US Air Force base leaves one dead

March 18, 2026
Civilian killed in Ukrainian strike on Russian city – governor  (PHOTOS)

Civilian killed in Ukrainian strike on Russian city – governor  (PHOTOS)

March 18, 2026

This Emirati billionaire put a voice to Gulf anger over Trump’s war in Iran

March 18, 2026
thehopper.news

Copyright © 2023 The Hopper New

Navigate Site

  • About
  • Advertise
  • Privacy & Policy
  • Contact

Follow Us

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Home
    • Home
    • About
    • Editorial Standards
    • Methodology & Sources
  • Briefings
    • Weekly
  • Analysis
  • Regions
    • Africa
    • Americas
    • Asia-Pacific
    • Europe & NATO
    • Middle East & North Africa
    • Russia & Eurasia
  • Themes
    • Energy & Reources
    • Intelligence & Security
    • Economics & Sanctions
    • Foreign Relations & Diplomacy
    • Cyber & Disinformation
  • Video
  • Aggregated
    • RT
    • Opinion
    • News
    • Geopolitics
    • Politics
    • Business
    • World

Copyright © 2023 The Hopper New

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.